• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cannara Biotech Inc (OP: LOVFF )

    0.5334 UNCHANGED
    Streaming Delayed Price Updated: 11:36 AM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cannara Biotech Inc

    < Previous 1 2 Next >
    Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
    Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
    Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Reports Q3 2024 Financial Results
    From Cannara Biotech (Québec) Inc.
    Via GlobeNewswire
    Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
    In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
    Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
    --News Direct-- 
    Via News Direct
    Topics Cannabis
    Exposures Cannabis
    The 7 Most Undervalued Cannabis Stocks to Buy in December
    These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential. 
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
    Nicholas Sosiak, CFO of Cannara Biotech (TSXV: LOVE.V) (OTCQB: LOVFF) (FRA: 8CB) was recently interviewed by Benzinga. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    7 Smoking-Hot 420 Stocks to Buy in 2023
    A blaze of renewed bullishness may be just around the corner for these seven cannabis plays, making them top 420 stocks to buy. 
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stock Movers For August 10, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
    Cannara Biotech Inc. 
    Via Benzinga
    Cannabis Stock Gainers And Losers From August 4, 2023
    Via Benzinga
    Cannabis Stock Gainers And Losers From July 25, 2023
    Via Benzinga
    Marijuana Stock Movers For August 1, 2023
    Via Benzinga
    Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
    Cannara Biotech Inc. 
    Via Benzinga
    Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing net revenue of CA$13 million ($9.6 million), a 76% increase, compared to... 
    Via Benzinga
    Cannabis Stock Movers For July 27, 2023
    Via Benzinga
    Olymbec Investments Increases Its Ownership In Cannara Biotech
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023. 
    Via Benzinga
    Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3... 
    Via Benzinga
    Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022,... 
    Via Benzinga
    Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and derivative product offerings, entered into the British Columbia (BC) market. 
    Via Benzinga
    Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd. 
    Via Benzinga
    Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021. 
    Via Benzinga
    Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking. 
    Via Benzinga
    Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
    Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022. 
    Via Benzinga
    The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
    Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
    Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July
    Canadian cannabis stocks took a beating In July, with the Canadian Cannabis LP Index posting a 9.8% loss while continuing the decl... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
    Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.